| Diverse role of TGF-β in kidney disease YY Gu, XS Liu, XR Huang, XQ Yu, HY Lan Frontiers in cell and developmental biology 8, 123, 2020 | 191 | 2020 |
| The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line J Xie, J Liu, H Liu, S Liang, M Lin, Y Gu, T Liu, D Wang, H Ge, S Mo Acta Pharmaceutica Sinica B 5 (6), 554-563, 2015 | 105 | 2015 |
| Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study YY Gu, M Zhang, H Cen, YF Wu, Z Lu, F Lu, XS Liu, HY Lan PloS one 16 (1), e0245209, 2021 | 82 | 2021 |
| Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway XZ Liao, LT Tao, JH Liu, YY Gu, J Xie, Y Chen, MG Lin, TL Liu, DM Wang, ... Cancer cell international 17, 1-14, 2017 | 63 | 2017 |
| Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3 YY Gu, MH Chen, BH May, XZ Liao, JH Liu, LT Tao, DM Sze, AL Zhang, ... Phytomedicine 51, 214-225, 2018 | 59 | 2018 |
| Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way J Xie, JH Liu, H Liu, XZ Liao, Y Chen, MG Lin, YY Gu, TL Liu, DM Wang, ... BMC cancer 16, 1-14, 2016 | 53 | 2016 |
| TGF-β in renal fibrosis: triumphs and challenges YY Gu, XS Liu, XR Huang, XQ Yu, HY Lan Future Medicinal Chemistry 12 (9), 853-866, 2020 | 46 | 2020 |
| Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer MH Chen, YY Gu, AL Zhang, DM Sze, SL Mo, BH May Pharmacological Research 171, 105778, 2021 | 40 | 2021 |
| Non-coding RNAs as biomarkers and therapeutic targets for diabetic kidney disease YY Gu, FH Lu, XR Huang, L Zhang, W Mao, XQ Yu, XS Liu, HY Lan Frontiers in pharmacology 11, 583528, 2021 | 37 | 2021 |
| Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines YQ Chen, HY Chen, QQ Tang, YF Li, XS Liu, FH Lu, YY Gu Frontiers in Pharmacology 13, 968226, 2022 | 34 | 2022 |
| Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro YY Gu, LP Liu, J Qin, M Zhang, Y Chen, D Wang, Z Li, JZ Tang, SL Mo Fitoterapia 94, 21-28, 2014 | 27 | 2014 |
| Transforming growth factor-β and long non-coding RNA in renal inflammation and fibrosis YY Gu, JY Dou, XR Huang, XS Liu, HY Lan Frontiers in Physiology 12, 684236, 2021 | 26 | 2021 |
| Salvia miltiorrhiza Bunge (Danshen) and Bioactive Compound Tanshinone IIA Alleviates Cisplatin-Induced Acute Kidney Injury Through Regulating PXR/NF-κB … JY Dou, M Zhang, H Cen, YQ Chen, YF Wu, F Lu, J Zhou, XS Liu, YY Gu Frontiers in Pharmacology 13, 860383, 2022 | 16 | 2022 |
| Conventional disease-modifying anti-rheumatic drugs combined with Chinese herbal medicines for rheumatoid arthritis: a systematic review and meta-analysis R Han, HC Ren, S Zhou, S Gu, YY Gu, DM Sze, MH Chen Journal of traditional and complementary medicine 12 (5), 437-446, 2022 | 15 | 2022 |
| The synergistic antitumor effect of tanshinone IIA plus adriamycin on human hepatocellular carcinoma xenograft in BALB/C nude mice and their influences on cytochrome P450 … TL Liu, LN Zhang, YY Gu, MG Lin, J Xie, Y Chen, JH Liu, XL Wu, SL Mo Advances in Medicine 2020 (1), 6231751, 2020 | 6 | 2020 |
| Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway Y Mo, X Jie, L Wang, C Ji, Y Gu, Z Lu, X Liu BMC Complementary Medicine and Therapies 21 (1), 207, 2021 | 5 | 2021 |
| Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs YY Gu, XS Liu, HY Lan Molecular Therapy 32 (2), 313-324, 2024 | 3 | 2024 |
| OPEN ACCESS EDITED BY X Zhang, Z Liu, E Soule, W Fan, L Shen, Y Wu, F Cao, D Zhou, S Chen, ... Combinational Immunotherapy of Cancer: Novel Targets, Mechanisms, and …, 2024 | | 2024 |
| Diverse Role of TGF YY Gu, XS Liu, XR Huang, XQ Yu, HY Lan Kidney Disease. Front. Cell Dev. Biol. 8: 123. doi: 10.3389/fcell, 2020 | | 2020 |
Hui Y LanChoh-Ming Li Professor of Biomedical Sciences,The Chinese University of Hong Kong在 cuhk.edu.hk 的电子邮件经过验证
